Track Ambu A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ambu A/S AMBFF · Stock Open Ambu A/S in new tab

11.40 USD
P/E
38.00
EPS
0.30
Yield
0.56%
P/B
3.22
ROE
8.45
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
P/E38.00
EPS0.30
Book Value3.54
Price to Book3.22
Debt/Equity9.39
Growth
Revenue Growth0.09%
Earnings Growth0.28%
Dividend
Dividend Yield0.56%
Annual dividends0.06 USD
Ex-Div. DateDec. 5, 2025
Payout21.35%

DCF valuation

Model fair value for Ambu A/S (AMBFF)
Result
Sign in to run the valuation for AMBFF.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Ambu A/S Logo Ambu A/S Analysis (AMBFF)

Denmark Health Care Official Website Stock

Is Ambu A/S a good investment? Ambu A/S (AMBFF) is currently trading at 11.40 USD.

In terms of valuation, the stock trades at a P/E ratio of 38.00. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Ambu A/S is expected to release its next earnings report on Nov. 5, 2026.

For income investors, Ambu A/S pays a dividend yield of 0.56%. With a payout ratio of 21%, the dividend appears sustainable.

Investor FAQ

Does Ambu A/S pay a dividend?

Yes, it pays an annual dividend of 0.06 USD (0.56% yield).

What asset class is Ambu A/S?

Ambu A/S is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 0.30.

Company Profile

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

Exchange Ticker
STU (Germany) 547A.SG
PNK (United States) AMBFF
CPH (Denmark) AMBU-B.CO
FRA (Germany) 547A.F
Trades
Dividend Yield
0.56%
Annual Dividends
0.06USD
Next Ex. Div Date
Dec. 5, 2025
Payout Ratio
21.35%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2026
0.06 USD
Dec. 22, 2026 (estimated) 0.0593
▸2025
0.06 USD
Dec. 8, 2025 0.0639
▸2024
0.05 USD
Dec. 9, 2024 0.0538
▸2021
0.04 USD
Dec. 17, 2021 0.0439
▸2020
0.05 USD
Dec. 14, 2020 0.0473
▸2019
0.06 USD
Dec. 20, 2019 0.0566
▸2018
0.06 USD
Dec. 17, 2018 0.0608
▸2017
0.29 USD
Dec. 18, 2017 0.2927
▸2016
0.22 USD
Dec. 15, 2016 0.2218
▸2015
0.14 USD
Dec. 15, 2015 0.1400
▸2014
0.62 USD
Dec. 22, 2014 0.6190
▸2013
0.23 USD
Dec. 18, 2013 0.2300
▸2012
0.53 USD
Dec. 19, 2012 0.5271
▸2011
0.35 USD
Dec. 21, 2011 0.3510
▸2010
0.44 USD
Dec. 22, 2010 0.4414
▸2009
0.29 USD
Dec. 22, 2009 0.2891
▸2008
0.29 USD
Dec. 22, 2008 0.2901
Upcoming Dividends
Name Payment Date Status Amount
Ambu A/S Dec 08, 2025 0.0639 USD
Stock Splits
Split Date Split Ratio to 1
Jan. 3, 2018 5:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion